M, N., RM, S., & S, S. (2022). Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options. Drug discovery today, 27(5), 1298. https://doi.org/10.1016/j.drudis.2022.01.010
Chicago Style (17th ed.) CitationM, Nakhjavani, Samarasinghe RM, and Shigdar S. "Triple-negative Breast Cancer Brain Metastasis: An Update on Druggable Targets, Current Clinical Trials, and Future Treatment Options." Drug Discovery Today 27, no. 5 (2022): 1298. https://doi.org/10.1016/j.drudis.2022.01.010.
MLA (9th ed.) CitationM, Nakhjavani, et al. "Triple-negative Breast Cancer Brain Metastasis: An Update on Druggable Targets, Current Clinical Trials, and Future Treatment Options." Drug Discovery Today, vol. 27, no. 5, 2022, p. 1298, https://doi.org/10.1016/j.drudis.2022.01.010.